mRNA Technology - Search News

FDA to review Moderna's mRNA flu vaccine

FDA won’t consider a new mRNA vaccine for flu despite the technology’s life-saving promise

The U.S. Food and Drug Administration is refusing to consider a new mRNA flu vaccine made by Moderna, the company revealed in a statement on Tuesday.

· 14h

Moderna’s mRNA Flu Vaccine Back Under FDA Review

· 1d

FDA reverses course, will review Moderna's mRNA flu vaccine

· 1d

FDA reverses course and will review Moderna’s mRNA-based flu shot

The Food and Drug Administration has reversed course and agreed to review Moderna’s application for the first mRNA-based flu vaccine under a revised approach, company and federal officials said Wednes...

· 1d

FDA Reverses Course and Will Now Review Moderna’s Flu Shot

· 1d

FDA reverses course and will review Moderna’s mRNA flu shot, company says

Morning Overview on MSN

New mRNA flu shot proves 30%+ more powerful at stopping influenza A

Moderna says its experimental mRNA influenza vaccine, mRNA-1010, showed more than 30% greater relative vaccine efficacy against influenza A than a licensed egg-based flu shot in a large Phase 3 trial enrolling 40,

BioSpace

Court Rejects Two Moderna Defenses in mRNA Vaccine Patent Row With Arbutus

Arbutus alleges that Moderna’s COVID-19 vaccine infringes on patents protecting its lipid nanoparticle delivery technology.

Yahoo

How RFK Jr.’s misguided science on mRNA vaccines is shaping policy

Add Yahoo as a preferred source to see more of our stories on Google. Health and Human Services Secretary Robert F. Kennedy Jr. canceled $500 million of funding for research on mRNA vaccine technology. He's seen here at a Sept. 4, 2025, hearing before the ...